Tuesday October 22, 2019

Online therapy: Help people with mental disorders

0
//
mental disorder

London: A new study has found that Cognitive Behavioral Therapy (CBT), a talk therapy that is based on the Internet, may help individuals affected by mental disorder.

Body dysmorphic disorder (BDD) causes a person to have a distorted view of how they look and to spend a lot of time worrying about their appearance. If left untreated, it can lead to hospitalisation, substance dependence and suicide.

The CBT programme is significantly helpful and improves BDD’s symptom severity, depression, and the quality of life, the study said.

The CBT therapy, which helps people manage their problems by changing the way one thinks and behaves, could be particularly useful in a stepped care approach, the findings showed.

The CBT programme, “has the potential to increase access to evidence-based psychiatric care for this mental disorder”, said the researchers from the Karolinska University Hospital in Stockholm, Sweden.

Mild to moderately affected patients can be offered CBT programme by their general practitioner, or other health professionals, thus freeing resources for more severe and complex patients to be treated in specialised settings, the researchers noted in the study published in the journal BMJ.

The researchers evaluated the effectiveness of a therapist guided internet-based CBT programme for body dysmorphic disorder compared with online supportive therapy.

The study involved 94 adult patients with a diagnosis of body dysmorphic disorder who randomly received either CBT programme or supportive therapy for 12 weeks.

None of the participants had any face-to-face contact with a therapist during treatment and both groups were followed for 3 months after the end of treatment.

Patients who underwent CBT programme showed significant improvements in their severity of symptoms, depression level, and the quality of life compared with those who had supportive therapy. These gains were maintained for at least three months after the end of treatment.

Participants in the supportive therapy group who crossed over to CBT programme after six months also improved their symptom scores.(IANS)(image: mental.disorder.net)

Next Story

E-Pharmacies to Grow to $3.7 Billion by 2022: CLSA

The Indian pharma market is valued at $20 billion and has been growing at 10-12 per cent

0
E-Pharmacies
According to CLSA, there are several E-Pharmacies operating currently but Netmeds, Pharmeasy, Medlife and 1mg have emerged as the key players with a pan-India reach. Pixabay

E-pharmacies are likely to grow seven times to $3.7 billion by CY22 as they aim to grab a large pie of the highly fragmented Indian market, according to a research note by foreign brokerage, CLSA.

The brick and mortar chemists have been protesting against the business models of online pharmacies and have gone on strike several times.

The Indian pharma market is valued at $20 billion and has been growing at 10-12 per cent. Continuation of current growth trends could propel the market to $35 billion by 2025, the report noted.

However, the distribution channel of the pharmacy market in India is highly unorganised and fragmented with over 80,000 distributors and more than 0.85 million brick and mortar retail outlets allowing room for organised and online pharmacies.

E-Pharmacies
The Indian market of E-Pharmacies is valued at $20 billion and has been growing at 10-12 per cent. Pixabay

According to CLSA, there are several e-pharmacies operating currently but Netmeds, Pharmeasy, Medlife and 1mg have emerged as the key players with a pan-India reach. Apollo Pharmacy with 3,500 stores is the largest offline pharmacy and is also piloting an e-pharma portal. These companies have cumulatively raised close to $400 million since starting out.

As per Frost and Sullivan, e-pharmacy is a nascent market worth $0.5 billion, but it is expected to grow nearly 7 times at 63 per cent compounded annual growth rate (CAGR) to $3.7 billion by 2022, riding higher internet penetration.

At present, e-pharmacies largely cater to subset of the chronic market (cardiac, diabetes where drugs purchases can be planned) and their penetration of the acute market has been tough.

Deep discounting and large promotional spends have been drivers of customer acquisition and sales growth. Most e-pharmacies are burning close to Rs 70-80 million per month and this is largely being funded by private equity money, the report noted

E-Pharmacies
At present, E-Pharmacies largely cater to subset of the chronic market (cardiac, diabetes where drugs purchases can be planned) and their penetration of the acute market has been tough. Pixabay

With draft guidelines for regulation of e-pharmacies issued, formalisation of the space on issue of final guidelines may also be an enabler for growth for these companies.

E-pharmacies currently comprise only 2-3 per cent of the India pharma market and thus have limited bargaining power while sourcing from the manufacturer.

ALSO READ: Emissions Trading Scheme in Surat Cuts Pollution, Hikes Profit

“Once e-pharmacies are able to garner 10-15 per cent share of the market, they are likely to have better bargaining power and could then be able to capture a larger pie of margins. Automatic substitution of doctor prescription to unbranded generics (Gx) could be a game changer for e-pharmacies. This may be possible once India enforces uniform quality standards,” CLSA said in the note. (IANS)